肾管状囊性癌(tubulocystic carcinoma of the kidney,TCC)是肾囊性上皮细胞肿瘤的主要形式,最早由PIERRE于1956年发现,2004年美加病理年会上被正式命名为肾管状囊性癌。在2016版世界卫生组织肾脏肿瘤分类中将其作为一种新增的肾细胞癌...肾管状囊性癌(tubulocystic carcinoma of the kidney,TCC)是肾囊性上皮细胞肿瘤的主要形式,最早由PIERRE于1956年发现,2004年美加病理年会上被正式命名为肾管状囊性癌。在2016版世界卫生组织肾脏肿瘤分类中将其作为一种新增的肾细胞癌亚型单独划分出来,目前全球报道约70例[1]。2018年我院收治1例肾管状囊性癌患者,报道如下。展开更多
Objective： The aim of our study was to explore the clinical experience of surgical treatment for primary tracheobronchial malignant tumors. Methods： The clinicopathological data of 18 patients with primary tracheobr...Objective： The aim of our study was to explore the clinical experience of surgical treatment for primary tracheobronchial malignant tumors. Methods： The clinicopathological data of 18 patients with primary tracheobronchial malignant tumors surgically treated from February 1994 to August 2007 were reviewed retrospectively. The surgical management included sleeve tracheal resection in 8 cases, lower trachea and carina resection with carina reconstruction in 4 cases, local enucleation of the tumor in 4 cases, left or right carino-pneumon-ection in 2 cases, and resection of the tracheal or bronchial tumor and reconstruction of the airway under cardiopulmonary bypass （CPB）in 6 cases. Results： Among the 18 cases, there were 7 adenoid cystic carcinomas, 9 squamous cell carcinomas, 1 lymphoepithelial-like carcinoma and 1 follicular non-Hodgkin tymphoma. All the cases recovered well except one who died of endotracheal bleeding and asphyxia at the 10th postoperative day. Conclusion： Surgical resection is the most effective treatment for primary tracheobronchial malignant tumors. The selection of operation modes should be individualized according to patients＇ condition. Both complete resection and safety should be taken into consideration simultaneously.展开更多
文摘肾管状囊性癌(tubulocystic carcinoma of the kidney,TCC)是肾囊性上皮细胞肿瘤的主要形式,最早由PIERRE于1956年发现,2004年美加病理年会上被正式命名为肾管状囊性癌。在2016版世界卫生组织肾脏肿瘤分类中将其作为一种新增的肾细胞癌亚型单独划分出来,目前全球报道约70例[1]。2018年我院收治1例肾管状囊性癌患者,报道如下。
文摘Objective： The aim of our study was to explore the clinical experience of surgical treatment for primary tracheobronchial malignant tumors. Methods： The clinicopathological data of 18 patients with primary tracheobronchial malignant tumors surgically treated from February 1994 to August 2007 were reviewed retrospectively. The surgical management included sleeve tracheal resection in 8 cases, lower trachea and carina resection with carina reconstruction in 4 cases, local enucleation of the tumor in 4 cases, left or right carino-pneumon-ection in 2 cases, and resection of the tracheal or bronchial tumor and reconstruction of the airway under cardiopulmonary bypass （CPB）in 6 cases. Results： Among the 18 cases, there were 7 adenoid cystic carcinomas, 9 squamous cell carcinomas, 1 lymphoepithelial-like carcinoma and 1 follicular non-Hodgkin tymphoma. All the cases recovered well except one who died of endotracheal bleeding and asphyxia at the 10th postoperative day. Conclusion： Surgical resection is the most effective treatment for primary tracheobronchial malignant tumors. The selection of operation modes should be individualized according to patients＇ condition. Both complete resection and safety should be taken into consideration simultaneously.
